Assessment of State and Federal Health Policies for Opioid Use Disorder Treatment During the COVID-19 Pandemic and Beyond

View Resource

Examines state-level policy data from government and nonprofit agencies related to treatment access and treatment retention for patients with Opioid Use Disorder (OUD) during the COVID-19 pandemic. Describes policy changes affecting telehealth coverage, delivery, and payment; issues of licensing and security; and the initiation and dispensing of treatment medications.

Seema Chosky Pessar, Anne Boustead, Yimin Ge, Rosanna Smart, Rosalie Liccardo Pacula

JAMA Health Forum, 2(11), e213833

11/2021

Document

Access · COVID-19 · Illicit drug use · Policy · Prescription drug misuse · Reimbursement and payment models · Telehealth